CAS: 31477-60-8; Ormeloxifene

上下游产品

CAS号84394-36-5 (3R,4R)-2,2-dim...

📜2,2-Dimethyl-3-Phenyl-7-Methoxychromene,N-(Pyrrolidino)Ethoxybenzene Hydrochloride置于aluminum (III) Chloride体系中,用 1,2-二氯乙烷 用作溶剂,化学反应生成1-[2-[4-(2,2-二甲基-7-甲氧基-3-苯基色满-4-基)苯氧基]乙基]吡咯烷
参考文献: An Improved Process For The Preparation Of Trans 3,4-Diarylchroman And Their Derivatives[fr] Procédé Amélioré Pour La Préparation De 3,4-Diarylchromane Et Leurs Dérivés
标题: An Improved Process For The Preparation Of Trans 3,4-Diarylchroman And Their Derivatives[fr] Procédé Amélioré Pour La Préparation De 3,4-Diarylchromane Et Leurs Dérivés

专利信息

专利号:US-7582653-B2
优先权日:2003-03-31
标 题 :Mercaptophenyl naphthyl methane compounds and synthesis thereof
权利人:COUNCIL SCIENT IND RES
摘要:Novel mercaptophenyl naphthyl methane compounds, their pharmaceutically acceptable salts and compositions comprised thereof are useful for the prevention or treatment of various medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma, cancer of breast, cancer of uterus, cancer of the cervix and cancer of the colon, threatened or habitual abortion, obesity, ovarian development or function, post-partum lactation and depression.

专利号:WO-2005102340-A1
优先权日:2003-05-30
标题 :Piperazine melanocortin-specific compounds
发明人：SHARMA SHUBH D; SHI YI-QUN; WU ZHIJUN; RAJPUROHIT RAMESH
权利人:PALATIN TECHNOLOGIES INC; SHARMA SHUBH D; SHI YI-QUN; WU ZHIJUN; RAJPUROHIT RAMESH
摘要:Melanocortin receptor-specific piperazine or ketopiperazine compounds having the structure (I); and stereoisomer and pharmaceutically acceptable salts thereof, where X is CH2 or C=O, R1, R2, and R3 are as described in the specification, preferably where R3 is a D-amino acid with at least one substituted or unsubstituted phenyl or naphthyl aromatic ring, and where R3 optionally further includes an amine capping group, a second amino acid residue or a second amino acid residue with an amine capping group, which compounds are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Methods of synthesis of compounds of structure (I), pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.